Texas Health Fort Worth’s Jane and John Justin Tower Set to Open April 2

Texas Health Fort Worth’s Jane and John Justin Tower opening caps a more than two-year-long, $300 million construction project that adds 400,000 square feet to the hospital.

The nine-story tower, which includes 144 beds, 15 surgery suites, and new pre- and postoperative suites services, is the largest construction project in Texas Health history.

Justin Tower reinforces Texas Health’s long-standing commitment to the Fort Worth community,” said Barclay Berdan, FACHE, CEO of Texas Health Resources and a former president of Texas Health Fort Worth. “What began as a small community hospital has evolved into a world-class medical center serving the 12th largest city in the U.S.”

Justin Tower will increase surgical capacity by almost 30%, with dedicated neurosurgery and orthopedics operating suites. The surgical suites are twice the size of existing operating rooms (ORs) to accommodate modern robotic and imaging technology and are sized to accommodate even larger equipment in the future.

“Our service area includes 1.2 million people in four counties, and that’s expected to grow by another 100,000 over the next five years,” said Joseph DeLeon, president of Texas Health Fort Worth. “The larger, more modern facilities allow us to treat this growing population with specialty services, including trauma, neuroscience, heart and vascular, and many others.”

In addition to the ORs, additional elements of Justin Tower were built with an eye to the future. All patient rooms are private and can be modified to provide varying levels of care, from general medical-surgical to critical care. Additional design elements include the use of natural light, patient-friendly way-finding, and indoor and outdoor spaces for visitors.

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”